Mesenkia Therapeutics

Biotechnology Research • Uppsala, Uppsala County, Sweden • 1-10 Employees

Company overview

Headquarters	Uppsala, Uppsala County, Sweden
Websites	mesenkiatherapeutics.com mesenkia.com
NAICS	541714
Founded	2023
Employees	1-10

Key Contact at Mesenkia Therapeutics

Moa Fransson

CEO

About Mesenkia Therapeutics

Mesenkia Therapeutics is a pre-clinical company built on state-of-the art research from the prominent Universities of Tokyo and Uppsala with the focus on prolonging progression free survival for patients with aggressive primary and recurrent glioblastoma. Mesenkia has an exciting program with a unique first-in-class biologic with the potential to reduce tumour volume and prolong survival in in patients with aggressive malignant brain tumours.

Mesenkia Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Mesenkia Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Mesenkia Therapeutics has never raised funding before.

Frequently asked questions

Mesenkia Therapeutics is located in Uppsala, Uppsala County, SE.

Mesenkia Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Mesenkia Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Mesenkia Therapeutics

Moa Fransson

CEO

4.8

40,000 users